Table 8. Meta-analysis of effectiveness outcomes, weaning from support or bridging to repeat heart transplant or VAD (random-effect model) Survival, percentage (95% confidence interval), I2 Proportion of patients weaned Proportion of Indication from support or patients weaned N studies N studies bridged to heart from support or (n pts) (n pts) transplant or bridged to heart bridged to VAD transplant (95% CI) (95% CI) 81% VAD support in post-transplant graft - - 5 (55) (54-98%), rejection or failure indication I2=70.3% 80% VAD support in post-LVAD placement 8 (82) (64-92%), - - right ventricular failure indication I2=58.6% Pts patients; VAD, ventricular assist device. –
Table 8. Meta-analysis of effectiveness outcomes, weaning from support or bridging to repeat heart transplant or VAD (random-effect model) Indication Survival, percentage (95% confidence interval), I2 N studies (n pts) Proportion of patients weaned from support or bridged to heart transplant or bridged to VAD (95% CI) N studies (n pts) Proportion of patients weaned from support or bridged to heart transplant (95% CI) VAD support in post-transplant graft rejection or failure indication - - 5 (55) 81% (54-98%), I2=70.3% VAD support in post-LVAD placement right ventricular failure indication 8 (82) 80% (64-92%), I2=58.6% - - Pts – patients; VAD, ventricular assist device.
ASAIO_2014_07_02_BORISENKO_ASAIO-D-14011R1_SDC1.docx